Anthropic’s Long-Term Benefit Trust appoints Vas Narasimhan to Board of Directors
Anthropic
Novartis CEO Vas Narasimhan joins Anthropic's Board of Directors to help guide the company's responsible AI development in life sciences and healthcare.Summary
The Anthropic Long-Term Benefit Trust has appointed Novartis CEO Vas Narasimhan to Anthropic’s Board of Directors. Narasimhan, a physician-scientist with extensive experience in the highly regulated pharmaceutical industry, joins the board to support Anthropic’s mission of balancing commercial success with responsible, long-term AI development for humanity. His appointment, which creates a majority of Trust-appointed directors on the board, is expected to provide valuable expertise in scaling safe, innovative technologies, particularly within the healthcare and life sciences sectors.
(Source：Anthropic)